Chemed logo

CHE - Chemed Share Price

$468.18 4.9  1.1%

Last Trade - 15/04/21

Large Cap
Market Cap ÂŁ5.43bn
Enterprise Value ÂŁ5.31bn
Revenue ÂŁ1.51bn
Position in Universe 1107th / 6851
Unlock CHE Revenue
Relative Strength (%)
1m -0.026%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -16.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1,543 1,577 1,667 1,783 1,939 2,080 2,066 2,189 +6.1%
+15.1 +2.3 +46.0 +26.0 +14.0 +29.5 -4.97 +9.35
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, ChemedCorporation revenues increased 7% to $2.08B. Net incomeincreased 45% to $319.5M. Revenues reflect Roto Rootersegment increase of 13% to $744.9M, Vitas segment increaseof 4% to $1.33B. Net income benefited from Vitas segmentincome increase of 58% to $294.9M, Roto Rooter segmentincome increase of 20% to $151.4M. Dividend per shareincreased from $1.24 to $1.32.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CHE
Graphical History


CHE Revenue Unlock CHE Revenue

Net Income

CHE Net Income Unlock CHE Revenue

Normalised EPS

CHE Normalised EPS Unlock CHE Revenue

PE Ratio Range

CHE PE Ratio Range Unlock CHE Revenue

Dividend Yield Range

CHE Dividend Yield Range Unlock CHE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CHE EPS Forecasts Unlock CHE Revenue
Profile Summary

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated April 2, 1970
Public Since May 27, 1971
No. of Shareholders: 1,442
No. of Employees: 15,544
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P 400 Mid Cap , S&P Composite 1500 ,
Exchange New York Stock Exchange
Shares in Issue 15,975,034
Free Float (0.0%)
Eligible for
CHE Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CHE
Upcoming Events for CHE
Tuesday 27th April, 2021
Q1 2021 Chemed Corp Earnings Release
Wednesday 28th April, 2021
Q1 2021 Chemed Corp Earnings Call
Monday 17th May, 2021
Chemed Corp Annual Shareholders Meeting
Tuesday 18th May, 2021 Estimate
Chemed Corp Annual Shareholders Meeting
Tuesday 27th July, 2021 Estimate
Q2 2021 Chemed Corp Earnings Release
Frequently Asked Questions for Chemed
What is the Chemed share price?

As of 15/04/21, shares in Chemed are trading at $468.18, giving the company a market capitalisation of ÂŁ5.43bn. This share price information is delayed by 15 minutes.

How has the Chemed share price performed this year?

Shares in Chemed are currently trading at $468.18 and the price has moved by 3.62% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Chemed price has moved by -29.67% over the past year.

What are the analyst and broker recommendations for Chemed?

Of the analysts with advisory recommendations for Chemed, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Chemed is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Chemed next release its financial results?

Chemed is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Chemed dividend yield?

The Chemed dividend yield is 0.28% based on the trailing twelve month period.

Does Chemed pay a dividend?

Last year, Chemed paid a total dividend of 1.32, and it currently has a trailing dividend yield of 0.28%. Looking ahead, Chemed has not announced an ex-dividend date yet.

When does Chemed next pay dividends?

Chemed has yet to annouce their ex-dividend date. The historic dividend yield on Chemed shares is currently 0.28%.

How do I buy Chemed shares?

To buy shares in Chemed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Chemed?

Shares in Chemed are currently trading at $468.18, giving the company a market capitalisation of ÂŁ5.43bn.

Where are Chemed shares listed? Where are Chemed shares listed?

Here are the trading details for Chemed:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: CHE
What kind of share is Chemed?

Based on an overall assessment of its quality, value and momentum, Chemed is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Chemed share price forecast 2021?

Shares in Chemed are currently priced at $468.18. At that level they are trading at 27.09% discount to the analyst consensus target price of 0.00.

Analysts covering Chemed currently have a consensus Earnings Per Share (EPS) forecast of 17.257 for the next financial year.

How can I tell whether the Chemed share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chemed. Over the past six months, the relative strength of its shares against the market has been -21.86%. At the current price of $468.18, shares in Chemed are trading at -4.3% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Chemed PE Ratio?

The Chemed PE ratio based on its reported earnings over the past 12 months is 25.78. The shares are currently trading at $468.18.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Chemed?

Chemed's management team is headed by:

Kevin McNamara - PRE
Joel Gemunder - IND
Patrick Grace - IND
Thomas Hutton - DRC
Walter Krebs - IND
George Walsh - CHM
Spencer Lee - EVP
David Williams - CFO
Andrea Lindell - IND
Nicholas Westfall - EVP
Who are the major shareholders of Chemed?

Here are the top five shareholders of Chemed based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 11.39% (1.82m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 8.28% (1.32m shares)
Neuberger Berman, LLC Investment Advisor/Hedge Fund
Percentage owned: 3.78% (604k shares)
Acadian Asset Management LLC Investment Advisor/Hedge Fund
Percentage owned: 3.07% (491k shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 2.8% (448k shares)
Similar to CHE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.